Cargando…

A new beginning: can omidubicel emerge as the next, viable alternative donor source?

Umbilical cord blood (UCB) transplantation (CBT) has been an important alternative donor option for patients lacking matched related donor (MRD) or unrelated donor (URD) grafts. Only 30% of patients with high-risk hematologic malignancies have a human leukocyte antigen (HLA)-identical sibling; subje...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gandhi, Arpita P., Newell, Laura F., Maziarz, Richard T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469227/ https://www.ncbi.nlm.nih.gov/pubmed/37664800 http://dx.doi.org/10.1177/20406207231192146

Ejemplares similares

Abstract 14 Omidubicel-Onlv: Robustness of the Manufacturing Process
por: Landau, Efrat, et al.
Publicado: (2023)

Abstract 2 Results of an Open Label Expanded Access Study of Omidubicel-onlv for Allogeneic Transplantation (allo-HCT) in Patients with Hematologic Malignancies
por: Horwitz, Mitchell, et al.
Publicado: (2023)

Mini-donor nephrectomy: A viable and effective alternative
por: Guleria, Sandeep
Publicado: (2010)

Abstract 9 Hematopoietic Stem Cell Transplantation (HSCT) with Omidubicel Leads to Robust Recovery and Diversity of T Cells
por: Szabolcs, Paul, et al.
Publicado: (2022)

Characterization and Function of Cryopreserved Bone Marrow from Deceased Organ Donors: A Potential Viable Alternative Graft Source
por: Johnstone, Brian H., et al.
Publicado: (2023)

Abstract 8 Health-Related Quality of Life (HRQL) Following Transplantation with Omidubicel Versus Umbilical Cord Blood (UCB) in Patients with Hematologic Malignancies: Results from a Phase III Randomized, Multicenter Study
por: Lin, Chenyu, et al.
Publicado: (2022)

Structural and Functional Characterization of Deceased Donor Stem Cells: A Viable Alternative to Living Donor Stem Cells
por: Rao, Prakash N., et al.
Publicado: (2019)

Abstract 6 Projected Impact of Omidubicel on Racial and Ethnic Disparities in Allogeneic Hematopoietic Cell Transplant Access and Outcomes for Patients with Hematologic Malignancies in the U.S.
por: Gergis, Usama, et al.
Publicado: (2022)

Absolute quantification of viable bacteria abundances in food by next-generation sequencing: Quantitative NGS of viable microbes
por: Kallastu, Aili, et al.
Publicado: (2023)

Saliva samples are a viable alternative to blood samples as a source of DNA for high throughput genotyping
por: Abraham, Jean E, et al.
Publicado: (2012)

Dynamic Changes in Microvascular Density Can Predict Viable and Non-Viable Areas in High-Risk Neuroblastoma
por: Privitera, Laura, et al.
Publicado: (2023)

Equivalence and noninferiority trials – are they viable alternatives for registration of new drugs? (III)
por: Pater, Cornel
Publicado: (2004)

How can natural products serve as a viable source of lead compounds for the development of new/novel anti-malarials?
por: Guantai, Eric, et al.
Publicado: (2011)

Treatment of impacted canines with aligners: An alternative and viable option
por: Mampieri, Gianluca, et al.
Publicado: (2021)

Coral affected by stony coral tissue loss disease can produce viable offspring
por: Mendoza Quiroz, Sandra, et al.
Publicado: (2023)

Abstract: Open-Source, Customizable, 3D-Printed Ocular Prosthetics as a Viable Alternative to Traditional Ocular Prosthetics
por: Alghothani, Yousef, et al.
Publicado: (2016)

Korean Valve Survey: Is This Just the Beginning? What Is the Next Step?
por: Lee, Seonhwa, et al.
Publicado: (2023)

Putting tobacco harm reduction in perspective: is it a viable alternative?
por: Jhanjee, Sonali
Publicado: (2016)

Abstract: A Viable Alternative to Wrist Fusion: The Motec Arthroplasty
por: Giwa, Lolade, et al.
Publicado: (2016)

PML body meets telomere: The beginning of an ALTernate ending?
por: Chung, Inn, et al.
Publicado: (2012)

Bioethanol from poplar clone Imola: an environmentally viable alternative to fossil fuel?
por: Guo, Miao, et al.
Publicado: (2015)

Alternative use of phage display: phage M13 can remain viable in the intestines of poultry without causing damage
por: Santos, Fabiana de Almeida Araújo, et al.
Publicado: (2022)

Can GPT-4 be a viable alternative for discussing complex cases in digital oral radiology? A critical analysis
por: Santana, Lucas Alves da Mota, et al.
Publicado: (2023)

How can we begin to measure recovery?
por: Dodge, Karen, et al.
Publicado: (2010)

Beginning at the Beginning
Publicado: (1924)

Bioethanol from poplar: a commercially viable alternative to fossil fuel in the European Union
por: Littlewood, Jade, et al.
Publicado: (2014)

At the End of Every Pandemic: Beginning a Pandemic Playbook to Respond to the Next
por: Goldschmidt, Peter G.
Publicado: (2022)

Correction: Alternative use of phage display: phage M13 can remain viable in the intestines of poultry without causing damage
por: Santos, Fabiana de Almeida Araújo, et al.
Publicado: (2022)

Fuel cells are a commercially viable alternative for the production of “clean” energy
por: Niakolas, Dimitris K., et al.
Publicado: (2015)

Gestational carriers: A viable alternative for women with medical contraindications to pregnancy
por: Anchan, Raymond M., et al.
Publicado: (2013)

Cataract surgery in mobile eye surgical unit: Safe and viable alternative
por: Sangameswaran, Rajesh Pioneer, et al.
Publicado: (2016)

Is Tenecteplase a Viable Alternative to Alteplase in the Treatment of Acute Ischemic Stroke?
por: Vaishnav, Anand Girish
Publicado: (2022)

Embryonic Stem Cells As an Alternate Marrow Donor Source: Engraftment without Graft-Versus-Host Disease
por: Burt, Richard K., et al.
Publicado: (2004)

Cystic duct anastomosis can be a viable option for biliary reconstruction in case of multiple ducts in right lobe living-donor liver transplantation
por: Vijayashanker, Aarathi, et al.
Publicado: (2021)

Is this the beginning of end for warfarin in bioprosthetic mitral valve recipients with atrial fibrillation? – New insights from RIVER trial
por: Sahu, Ankit Kumar, et al.
Publicado: (2021)

New Beginnings
por: Wang, Jeffrey C., et al.
Publicado: (2020)

New beginnings
por: Kühnel, Karin
Publicado: (2022)

New Beginnings
por: “Sam” Samaranayake, Lakshman
Publicado: (2022)

Proximal Tibia Bone Graft: An alternative Donor Source especially for Foot and Ankle Procedures
por: Jia, TY, et al.
Publicado: (2015)

Human Tissue in the Evaluation of Safety and Efficacy of New Medicines: A Viable Alternative to Animal Models?
por: Coleman, Robert A.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_lec879jn16jqc192iuau9l8fkj